APA (7th ed.) Citation

Berlanga-Acosta, J., Cibrian, D., Valiente-Mustelier, J., Suárez-Alba, J., García-Ojalvo, A., Falcón-Cama, V., . . . Guillén-Nieto, G. (2024). Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms. Frontiers in pharmacology, 15, 1402138. https://doi.org/10.3389/fphar.2024.1402138

Chicago Style (17th ed.) Citation

Berlanga-Acosta, Jorge, Danay Cibrian, Juan Valiente-Mustelier, José Suárez-Alba, Ariana García-Ojalvo, Viviana Falcón-Cama, Baohong Jiang, Linlin Wang, and Gerardo Guillén-Nieto. "Growth Hormone Releasing Peptide-6 (GHRP-6) Prevents Doxorubicin-induced Myocardial and Extra-myocardial Damages by Activating Prosurvival Mechanisms." Frontiers in Pharmacology 15 (2024): 1402138. https://doi.org/10.3389/fphar.2024.1402138.

MLA (9th ed.) Citation

Berlanga-Acosta, Jorge, et al. "Growth Hormone Releasing Peptide-6 (GHRP-6) Prevents Doxorubicin-induced Myocardial and Extra-myocardial Damages by Activating Prosurvival Mechanisms." Frontiers in Pharmacology, vol. 15, 2024, p. 1402138, https://doi.org/10.3389/fphar.2024.1402138.